Halliburton's $42 Price Target From BMO Signals More Runway After a Monster 2026 - 24/7 Wall St. S&P 5006,618.60 +0.13% Dow Jones46,547.80 +0.14% Nasdaq 10024,307.00 +0.29% Russell 20002,545.32 +0.32% FTSE 10010,116.80 +1.00% Nikkei 22554,008.00 +1.18% Stock Market Live March 25, 2026: S&P 500 (SPY) Roller Coaster Ride Continues Investing Halliburton's $42 Price Target From BMO Signals More Runway After a Monster 2026 By Joel SouthPublished Mar 25, 10:32AM EDT Quick Read Halliburton (HAL) generated $1.5B in ...

Core Insights - Dollar General Corporation is a leading retail chain in the United States, offering a variety of products at affordable prices and competing with discount retailers like Dollar Tree and Family Dollar [1] Financial Performance - Dollar General reported impressive fourth-quarter fiscal 2025 results with an earnings per share (EPS) of $1.93, exceeding the Zacks Consensus Estimate of $1.61, marking a significant year-over-year increase of 121.8% [3][6] - The company's sales grew by 5.9%, with same-store sales increasing by 4.3%, driven by higher customer traffic and gains in both consumable and non-consumable categories [3] Stock Performance and Guidance - Despite strong financial results, Dollar General's shares experienced a 5% decline in trading hours due to fiscal 2026 guidance that fell short of investor expectations, anticipating sales growth of 3.7% to 4.2% and an EPS range of $7.10 to $7.35 [4][6] - Analyst Corey Tarlowe from Jefferies set a price target of $170 for Dollar General, suggesting a potential upside of approximately 25.05% from its current trading price of $135.95 [2][6] Expansion Plans - Dollar General plans to open 450 new stores across the United States, indicating ongoing expansion efforts [5][6] - The company's market capitalization is approximately $29.93 billion, with a trading volume of 8,000,822 shares [5]

Core Viewpoint - ANI Pharmaceuticals (ANIP) shares have shown a slight increase of 0.1% over the past four weeks, closing at $76.29, with analysts suggesting a potential upside of 44.8% based on a mean price target of $110.5 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $11.89, indicating variability among analysts; the lowest estimate is $90.00 (an 18% increase), while the highest is $124.00 (a 62.5% increase) [2] - Analysts' price targets can often mislead investors, as empirical research shows that they rarely indicate the actual price direction of a stock [7] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - There is growing optimism among analysts regarding ANIP's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 12.1% over the past month, with four estimates increasing and no negative revisions [12] - ANIP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] Conclusion on Price Movement - While consensus price targets may not reliably predict the extent of ANIP's gains, they do provide a useful guide for the direction of price movement [14]

Core Viewpoint - Kontoor Brands (KTB) has shown a significant price increase of 9.8% over the past four weeks, with a mean price target of $92.67 indicating a potential upside of 27% from the current price of $72.95 [1] Price Targets and Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $22.01, indicating variability among analysts. The lowest estimate is $50.00, suggesting a 31.5% decline, while the highest target is $131.00, indicating a potential surge of 79.6% [2] - Analysts' price targets can often mislead investors, as empirical research shows that these targets rarely indicate the actual price direction of a stock [7] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - There is growing optimism among analysts regarding KTB's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 11.6%, with one estimate moving higher and no negative revisions [12] - KTB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of KTB's potential gains, the implied direction of price movement appears to be a useful guide for investors [14]

Core Viewpoint - SS&C Technologies (SSNC) shows potential for significant upside, with a mean price target of $100.13 indicating a 33.9% increase from its current price of $74.78 [1] Price Targets - The average price target consists of eight estimates ranging from a low of $86.00 to a high of $112.00, with a standard deviation of $8.27, suggesting a variability in analyst predictions [2] - The lowest estimate indicates a 15% increase, while the highest suggests a 49.8% upside [2] Analyst Sentiment - Analysts exhibit strong agreement on SSNC's ability to exceed previous earnings estimates, which supports the expectation of stock price appreciation [4][11] - The Zacks Consensus Estimate for the current year has risen by 3.1% over the past month, with four estimates increasing and no negative revisions [12] Zacks Rank - SSNC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, they should be approached with skepticism as they can mislead investors; analysts may set overly optimistic targets due to business incentives [3][8][10]

Core Viewpoint - On Holding (ONON) shares have increased by 1.8% over the past four weeks, closing at $46.76, with a mean price target of $60.02 indicating a potential upside of 28.4% according to Wall Street analysts [1] Group 1: Price Targets and Analyst Estimates - The mean estimate consists of 22 short-term price targets with a standard deviation of $10.3, where the lowest estimate is $30.00 (indicating a 35.8% decline) and the highest is $85.00 (indicating an 81.8% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9] Group 2: Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about ONON's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has increased while there have been no negative revisions, leading to a 0.7% increase in the Zacks Consensus Estimate for the current year [12] Group 3: Zacks Rank and Investment Implications - ONON holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - OrthoPediatrics (KIDS) has shown a significant price increase of 11.2% over the past four weeks, with a mean price target of $25.5 indicating a potential upside of 32.7% from its current price of $19.22 [1] Price Targets and Analyst Consensus - The average price target consists of eight estimates ranging from a low of $22.00 to a high of $34.00, with a standard deviation of $4.28, suggesting a variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 14.5%, while the highest suggests a 76.9% upside [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Upside Potential - Analysts have shown increasing optimism about KIDS' earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 7%, with one estimate moving higher and no negative revisions [12] - KIDS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, the direction implied by these targets appears to be a useful guide for further research [14]

Group 1 - Atlanta Braves Holdings (BATRK) shares have increased by 9.5% over the past four weeks, closing at $43.71, with a mean price target of $56.25 indicating a potential upside of 28.7% [1] - The average price targets range from a low of $45.00 to a high of $69.00, with a standard deviation of $11.59, suggesting a variability in estimates among analysts [2] - Analysts show strong agreement on BATRK's ability to report better earnings than previously predicted, which supports the view of potential upside [4] Group 2 - The Zacks Consensus Estimate for BATRK's current year earnings has increased by 129.3% over the last 30 days, with two estimates moving higher and no negative revisions [12] - BATRK holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can indicate the direction of price movement, which appears to be a good guide [14]

Core Viewpoint - Exponent (EXPO) shares have increased by 2.3% recently, closing at $73.1, with analysts suggesting a potential upside of 25.4% based on a mean price target of $91.67 [1] Price Targets and Analyst Estimates - The mean price target includes three short-term estimates with a standard deviation of $7.64, indicating variability among analysts; the lowest estimate is $85.00 (16.3% increase), while the highest is $100.00 (36.8% increase) [2] - A low standard deviation suggests a strong consensus among analysts regarding the stock's price direction, although it does not guarantee that the stock will reach the average target [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about EXPO's earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases; the Zacks Consensus Estimate for the current year has risen by 1.4% [4][12] - EXPO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors; empirical research indicates that they often do not accurately predict stock price movements [7][10] - Analysts may set optimistic price targets due to business incentives, which can inflate expectations; thus, investors should approach these targets with skepticism [8][10]

Core Viewpoint - Dolby Laboratories (DLB) has shown a recent stock price increase of 3.3% over the past four weeks, with a mean price target of $89.25 indicating a potential upside of 40.2% from the current price of $63.65 [1] Price Targets and Estimates - The mean estimate for DLB comprises four short-term price targets with a standard deviation of $19, where the lowest estimate is $68.00 (6.8% increase) and the highest is $114.00 (79.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Analyst Sentiment and Earnings Estimates - Analysts are optimistic about DLB's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a 6.8% increase over the past month with two upward revisions and no negative revisions [11][12] - DLB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows that they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]